| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.93B | 46.37B | 43.06B | 38.89B | 34.31B | 31.67B |
| Gross Profit | 19.65B | 21.56B | 18.27B | 14.19B | 11.28B | 10.40B |
| EBITDA | 10.06B | 12.28B | 9.57B | 6.66B | 4.89B | 4.47B |
| Net Income | 6.78B | 8.44B | 6.41B | 4.67B | 3.17B | 3.03B |
Balance Sheet | ||||||
| Total Assets | 48.55B | 61.10B | 53.57B | 46.63B | 43.59B | 38.90B |
| Cash, Cash Equivalents and Short-Term Investments | 14.00B | 19.92B | 15.54B | 11.83B | 11.48B | 11.55B |
| Total Debt | 752.00M | 482.00M | 644.00M | 755.00M | 425.00M | 382.00M |
| Total Liabilities | 8.81B | 14.24B | 14.07B | 12.16B | 12.51B | 10.03B |
| Stockholders Equity | 39.74B | 46.86B | 39.49B | 34.46B | 31.08B | 28.86B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.57B | 8.01B | 4.17B | 3.44B | 1.26B |
| Operating Cash Flow | 0.00 | 11.04B | 8.13B | 4.27B | 3.52B | 1.36B |
| Investing Cash Flow | 0.00 | -5.82B | -4.28B | -2.12B | -2.20B | -1.44B |
| Financing Cash Flow | 0.00 | -2.38B | -1.64B | -2.11B | -989.00M | -1.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥157.35B | 14.32 | ― | 3.23% | 5.32% | -3.12% | |
80 Outperform | ¥28.86B | 13.32 | ― | 2.89% | 11.21% | 19.46% | |
80 Outperform | ¥82.44B | 8.26 | ― | 2.31% | 3.01% | 4.40% | |
79 Outperform | ¥170.21B | 16.69 | ― | 1.83% | 7.69% | 31.56% | |
72 Outperform | ¥23.25B | 7.24 | ― | 2.84% | 4.18% | 2.42% | |
66 Neutral | ¥9.18B | 7.40 | ― | 2.45% | 14.74% | -73.19% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |